Recent research demonstrates that under sensing arginine deficiency, SAMD4B is released by Bcl2-associated athanogene 2 (BAG2) and promotes β-catenin degradation to stabilize ATF4, thereby promoting tumor cell survival [30]. The gene discussed is BAG2; the disease is neoplasm.